Home › Graves Disease › Texas
Graves Disease clinical trials in Texas
8 studies for Graves Disease are looking for participants at sites in Texas.
Cities in Texas
A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease
- Research Institute of Dallas, Dallas
- Juno Research, Houston
- Clinic of Endocrinology, Houston
- and 5 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07570316Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
- Site-081, Amarillo
- Site-055, Dallas
- Site-020, Dallas
- and 8 more
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Sep 17, 2026 · NCT07661056Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease
- Site 100, Amarillo
- Site 117, Conroe
- Clinical Research Site, Dallas
- and 6 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT07682896A Study to Learn About The Effects of Felzartamab on Thyroid Function and Its Safety in Adults With Graves' Disease Ages 18 to 75 Years Old
- M3 Wake Research - Dallas, Dallas
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 4, 2026 · NCT07722546A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
- Site Number - 1002, Austin
- Site Number - 1067, Bellaire
- Site Number - 1019, Dallas
- and 5 more
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Aug 25, 2026 · NCT06727604A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
- Site Number - 1029, Dallas
- Site Number - 1002, El Paso
- Site Number - 1003, Fort Worth
- and 6 more
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Aug 25, 2026 · NCT07018323NEXUS Study: A Study to Test Single and Multiple Doses of MER511 Given to Adults With Graves' Disease
- Site # 1113, DeSoto
- Site # 1105, Webster
RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Aug 24, 2026 · NCT07305818Study of BHV-1300 in Graves' Disease
- Site-109, Dallas
- Site-106, Houston
- Site-101, Houston
- and 1 more
RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Jul 31, 2026 · NCT06980649From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.